Description

Corteva: Why Its Separation Timing Matters MORE Than First Quarter Strength!

Corteva Agriscience reported a strong first quarter in 2026, with both its Seed and Crop Protection segments delivering double-digit EBITDA growth and over 200 basis points of margin expansion. Organic sales increased by 7%, comprised of a 9% rise in Seed and 4% in Crop Protection. This performance was supported by a favorable timing shift in North America, an early start to the planting season due to cooperative weather, and volume growth across all regions. Seed benefited from price/mix improvements and volume growth, including strong demand for the Brevant retail brand, while Crop Protection experienced volume increases driven by new products and spinosyns, offsetting a 2% decline in pricing predominantly in Latin America. The company reaffirmed its full-year guidance, expecting operating EBITDA of $4 billion to $4.2 billion, margins between 22% and 23%, and operating EPS of $3.45 to $3.70, representing about 7% growth at the midpoint.